Ceribell Inc. (NASDAQ: CBLL) received FDA 510(k) clearance for its delirium monitoring solution, marking the first FDA-cleared device for delirium ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE